Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay

M Odette Gore1, Stephen L Seliger2, Christopher R Defilippi2

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

Insights

The 99th percentile upper reference limit for high-sensitivity cardiac troponin T (hs-cTnT) varies significantly by age and sex. Current myocardial infarction cutoffs may lead to over-diagnosis in certain populations.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Population Health

Background:

  • The current 14 ng/l cutoff for myocardial infarction diagnosis using high-sensitivity cardiac troponin T (hs-cTnT) is based on limited data.
  • Existing cutoffs lack comprehensive characterization of healthy populations.

Purpose of the Study:

  • To establish the 99th percentile upper reference limit for hs-cTnT in three large, independent cohorts.
  • To investigate the influence of age, sex, and race on hs-cTnT levels.

Main Methods:

  • Analysis of data from the Dallas Heart Study (DHS), Atherosclerosis Risk in Communities (ARIC) Study, and Cardiovascular Health Study (CHS).
  • Definition of reference subcohorts excluding individuals with cardiovascular disease, kidney disease, or subclinical heart conditions.
  • Stratified analysis by age, sex, and race.

Main Results:

  • The 99th percentile hs-cTnT values varied across cohorts and between subcohorts (e.g., 18-36 ng/l in subcohort 1, 14-28 ng/l in subcohort 2).
  • Values increased with age and were higher in men across all cohorts.
  • Over 10% of men aged 65-74 without cardiovascular disease exceeded the current 14 ng/l threshold.

Conclusions:

  • A uniform 14 ng/l cutoff for hs-cTnT may result in over-diagnosis of myocardial infarction, especially in elderly men.
  • Age- and sex-specific cutoff values for hs-cTnT require clinical validation.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495